Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Lauren Ogden

Gynecology Baton Rouge, LA Medical Doctor

NPI 1609909670 CMS profile 608253

5131 Odonovan Dr, Suite 201, Baton Rouge, LA 70808

Open in the dashboard

General payments

$2,511

152 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Lauren Ogden of Baton Rouge, LA is reported in the CMS Open Payments database as having received $2,511 across 152 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 77th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $19 1
2022 General $426 23
2021 General $775 44
2020 General $376 21
2019 General $915 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lauren Ogden
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Lauren Ogden were reported at $0. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Lauren Ogden Gynecology median Middle half National median
2019 $915 $199 $66–$472 $163
2020 $376 $114 $42–$287 $114
2021 $775 $141 $42–$430 $132
2022 $426 $173 $52–$532 $149
2023 $0 $170 $57–$501 $160
2024 $19 $157 $50–$424 $164
2025 $0 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Amgen Inc. $466 26 payments
  2. AbbVie, Inc. $310 15 payments
  3. Novo Nordisk Inc $292 23 payments
  4. Lilly USA, LLC $190 13 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $165 10 payments
  6. Astellas Pharma US Inc $150 8 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $135 6 payments
  8. Supernus Pharmaceuticals, Inc. $120 8 payments
  9. Sanofi-Aventis U.S. LLC $80 5 payments
  10. GlaxoSmithKline, LLC. $53 4 payments
  11. Other $551 34 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $2,497 151 payments
  2. Education $14 1 payment
Products named General payments · program years 2019–2024
  1. Prolia $319 17 payments
  2. EVENITY $272 15 payments
  3. Ozempic $243 20 payments
  4. SPIRIVA RESPIMAT $180 12 payments
  5. TRULICITY $154 10 payments
  6. MYRBETRIQ $150 8 payments
  7. TROKENDI XR $120 8 payments
  8. AIMOVIG $120 7 payments
  9. UBRELVY $118 6 payments
  10. TRINTELLIX $114 5 payments
  11. Other $1,706 102 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record